Genomic Plasticity of the Human Fungal Pathogen Candida albicans
Open accessThe DOI matches its Crossref record; 219 of the 221 references it cites were found in a registry or an index.
Abstract
The genomic plasticity of Candida albicans , a commensal and common opportunistic fungal pathogen, continues to reveal unexpected surprises. Once thought to be asexual, we now know that the organism can generate genetic diversity through several mechanisms, including mating between cells of the opposite or of the same mating type and by a parasexual reduction in chromosome number that can be accompanied by recombination events (2, 12, 14, 53, 77, 115). In addition, dramatic genome changes can appear quite rapidly in mitotic cells propagated in vitro as well as in vivo . The detection of aneuploidy in other fungal pathogens isolated directly from patients (145) and from environmental samples (71) suggests that variations in chromosome organization and copy number are a common mechanism used by pathogenic fungi to rapidly generate diversity in response to stressful growth conditions, including, but not limited to, antifungal drug exposure. Since cancer cells often become polyploid and/or aneuploid, some of the lessons learned from studies of genome plasticity in C. albicans may provide important insights into how these processes occur in higher-eukaryotic cells exposed to stresses such as anticancer drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The inter-isolate heterogeneity is likely due to genetic differences that contribute to several other clinically relevant phenotypes, including biofilm formation, filamentous growth responses and sensitivity to temperature52,60,79,80.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [79]
In the citing paper
“Indeed, the genomes of drug-resistant strains isolated following clinical treatment often exhibit large-scale changes, such as loss of heterozygosity (LOH) (Coste et al., 2006; Dunkel and Morschhauser, 2011), copy-number variation (CNV), including short segmental CNV, and whole chromosome aneuploidy (Selmecki et al., 2010) accompanied by point mutations.”
From The evolution of drug resistance in clinical isolates of Candida albicans. (2015) · cites this paper as Selmecki et al., 2010
In the citing paper
“High genomic plasticity is one of the characteristics of Candida yeasts that enables their fast adaptation to varying environments [62,63,64].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [64]
In the citing paper
“On the other hand, alternative genomic changes involving copy-number variation (CNV), including short segmental CNV [64] and loss of heterozygosity (LOH) (in heterozygous species such as C. albicans), are also proposed to drive fast adaptation [81,132].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [64]
Citations
Cites
Items 201–219 of 219
Rohou, H., Francisci, S., Rinaldi, T., Frontali, L., & Bolotin‐Fukuhara, M. (2001) · Yeast · doi:10.1002/1097-0061(200102)18:3<195::aid-yea660>3.0.co;2-l · Cited by 24
Mechanisms of genetic instability revealed by analysis of yeast spindle pole body duplication
Chial, H. J., & Winey, M. (1999) · Biology of the Cell · doi:10.1111/j.1768-322x.1999.tb01099.x · Cited by 23
Duncan, J. C. (2008) · Frontiers in bioscience · doi:10.2741/3189 · Cited by 22
Andaluz, E., Gómez‐Raja, J., Hermosa, B., Ciudad, T., Rustchenko, E. P., Calderone, R., & Larriba, G. (2007) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2007.01.005 · Cited by 22
Natural Auxotrophic Heterozygosity inCandida Albicans
Poulter, R. T. M. (1987) · CRC Critical Reviews in Microbiology · doi:10.3109/10408418709104452 · Cited by 22 · cited 1×
“Early investigations identified many different genes encoding nutritional markers, such as genes required for the biosynthesis of methionine and cysteine, that are heterozygous (147, 201, 203).”
BackgroundTissue Infection and Site-specific Gene Expression in Candida albicans
Fradin, C., & Hube, B. (2003) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(03)53008-8 · Cited by 21
Chromosome cohesion and the spindle checkpoint
Díaz-Martínez, L. A., & Clarke, D. J. (2009) · Cell Cycle · doi:10.4161/cc.8.17.9403 · Cited by 21
Kabir, M. A., & Rustchenko, E. P. (2005) · Gene · doi:10.1016/j.gene.2004.11.029 · Cited by 20
Iwaguchi, S., Sato, M., Magee, B. B., Magee, P. T., Makimura, K., & Suzuki, T. (2001) · Yeast · doi:10.1002/yea.748 · Cited by 19 · cited 2×
“For example, some aneuploidies provide a selective advantage for growth on specific carbon sources (86, 87, 160).”
BackgroundElectrophoretic karyotypes of isolates ofCandida albicansfrom hospitalized patients
Doi, M., Mizuguchi, I., Homma, M., & Tanaka, K. (1994) · Medical Mycology · doi:10.1080/02681219480000181 · Cited by 15 · cited 2×
“albicans are an indication of the extensive GCRs that can occur during growth in the host (9, 47, 48, 142, 160).”
BackgroundElectrophoretic Karyotypes of Candida Yeasts Recurrently Isolated from Single Patients
Doi, M., Mizuguchi, I., Homma, M., & Tanaka, K. (1994) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1994.tb01739.x · Cited by 14 · cited 1×
“albicans are an indication of the extensive GCRs that can occur during growth in the host (9, 47, 48, 142, 160).”
BackgroundCorrelation between polyploidy and auxotrophic segregation in the imperfect yeast Candida albicans
Suzuki, T., Hitomi, A., Magee, P. T., & Sakaguchi, S. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.11.3345-3353.1994 · Cited by 12
The antigens of Candida albicans.
HASENCLEVER, H. F. (1965) · PubMed · doi:10.1164/arrd.1965.92.1.150 · Cited by 11
Sanz, M., Valle, R., & Roncero, C. (2007) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2007.00264.x · Cited by 11 · cited 1×
“The phenotypic advantages of certain alleles and the presence of specific haplotypes in drug-resistant isolates have been analyzed (39, 50, 141, 165).”
BackgroundMarshall, O. J., & Choo, K. H. A. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000370 · Cited by 11
Analysis of hybrids of Candida albicans formed by protoplast fusion
Law, C., Kavanagh, K. A., & Whittaker, P. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb06617.x · Cited by 9 · cited 1×
“albicans, tetraploids were generated through protoplast fusion between cells whose cell walls had been digested enzymatically (102, 166, 202).”
MethodIncreased resolution of large DNA fragments by a two dimensional pulse field gel electrophoresis
Sanséau, P., Tiffoche, C., Kahloun, A.-E., Collin, O., Rolland, J., & Pennec, J. P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90060-m · Cited by 6 · cited 1×
“A PFGE apparatus has two alternating electric fields, one homogenous and one nonhomogenous, while the orthogonal field alternation gel electrophoresis (OFAGE) apparatus has two nonhomogenous fields (24, 163).”
BackgroundChromosomal aneuploidy in Saccharomyces cerevisiae.
Spencer, F. A., Connelly, C. J., Gerring, S. L., Shero, J. H., Sikorski, R. S., & Hieter, P. (1989) · PubMed · Cited by 3
But Maybe Counting Is the Easiest Part
Husted, R. F. (2001) · Science · doi:10.1126/science.294.5548.1834a · Cited by 1
Research works printed but not linked: 5
- 10.1002/1097-0061(200102)18:3<261::aid-yea670>3.0.co;2-w · doi:10.1002/1097-0061(200102)18:3<261::aid-yea670>3.0.co;2-w
- 10.1128/mcb.7.1.199-208.1987 · doi:10.1128/mcb.7.1.199-208.1987 · Paper page
- 10.1128/mcb.8.11.4721-4726.1988 · doi:10.1128/mcb.8.11.4721-4726.1988
- 10.1128/mcb.2.7.853-862.1982 · doi:10.1128/mcb.2.7.853-862.1982
- 10.1128/mr.54.3.226-241.1990 · doi:10.1128/mr.54.3.226-241.1990 · Paper page
Cited by
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Resistance of Candida to azoles and echinocandins worldwide
Pristov, K. E., & Ghannoum, M. A. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.028 · Cited by 706
“The development of Candida species resistance to antifungal drugs seems to be due to the genomic plasticity of the fungus [22].”
BackgroundMechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
“albicans isolates that evolved resistance in patients revealed that mutations in these genes often arise in the heterozygous state and become homozygous by LOH (Coste et al. 2007; Selmecki et al. 2010).”
BackgroundDrug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Self-citationGenetic control of Candida albicans biofilm development
Finkel, J. S., & Mitchell, A. P. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2475 · Cited by 612
“Persisters do not have the long-term stability of mutants, but are phenotypic variants that may arise from an epigenetic change or, perhaps, transient aneuploid”
Metadata
- Authors
- Selmecki, A., Forche, A., & Berman, J.
- Affiliations
- Harvard University (US)
- Bowdoin College (US)
- University of Minnesota (US)
- Corresponding author
- Berman, Judith
- Venue
- Eukaryotic Cell
- Publisher
- American Society for Microbiology
- Published
- 2010-07
- Volume
- 9
- Issue
- 7
- Pages
- 991-1008
- ISSN
- 1535-9778 (ISSN-L)
- 1535-9786
- PMC
- PMC2901674
- OpenAlex
- W2117709732
- Cited by
- 247
- References
- 221
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 12 · 2023: 11 · 2022: 18 · 2021: 15 · 2020: 17 · 2019: 24 · 2018: 26 · 2017: 24 · 2016: 12 · 2015: 17 · 2014: 16 · 2013: 12 · 2012: 15
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Eukaryotic Cell (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Bowdoin - Digital Commons (Bowdoin College) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (NIAID R01AI075096, NIH NIAID R01AI0624273)
- National Institute of Allergy and Infectious Diseases (R01AI075096, R01AI062427)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- Candida albicans, genome plasticity, aneuploidy, chromosome number reduction, mating, genetic diversity, copy number variation, polyploidy, chemoresistance, fungal pathogenesis
- MeSH terms
- Aneuploidy, Candida albicans, Humans, Neoplasms, Stress, Physiological, Genetic Variation, Genome, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.